Smoking denial in cardiovascular disease studies

Advances in Experimental Medicine and Biology

Volumn 788, Issue , 2013, Pages 35-38

  Wallner Liebmann, S J ^a   Grammer, T B ^b   Siekmeier, R ^c   Mangge, H ^a   Marz W ^a,b   Renner, Wilfried ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b SYNLAB ACADEMY   (Germany)

^c Federal Institute for Drugs and Medical Devices (BfArM)   (Germany)

Author keywords

Cardiovascular disease; Cotinine; Epidemiology; Nicotine exposure; Smoking denial

Indexed keywords

BIOCHEMICAL MARKER; COTININE;

AGE; ANGIOCARDIOGRAPHY; ARTICLE; BIOCHEMICAL COMPOSITION; BLOOD LEVEL; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DENIAL; EDUCATIONAL STATUS; FALSE NEGATIVE RESULT; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUESTIONNAIRE; RISK ASSESSMENT; RISK FACTOR; SELF REPORT; SEX RATIO; SMOKING; SMOKING HABIT; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION;

EID: 84881031335     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-94-007-6627-3_5     Document Type: Article

References (18)

1. Benowitz, N. L., & Jacob, P., 3rd. (1993). Nicotine and cotinine elimination pharmacokinetics in smokers and nonsmokers. Clinical Pharmacology and Therapeutics, 53, 316-323. (Pubitemid 23094374)
2. Bramer, S. L., & Kallungal, B. A. (2003). Clinical considerations in study designs that use cotinine as a biomarker. Biomarkers, 8, 187-203. (Pubitemid 37184377)
3. Brooks, D. R., Mucci, L. A., Hatch, E. E., Cnattingius, S. (2004). Maternal smoking during pregnancy and risk of brain tumors in the offspring. A prospective study of 1.4 million Swedish births. Cancer Causes Control, 15, 997-1005. (Pubitemid 41449280)
4. Caraballo, R. S., Giovino, G. A., Pechacek, T. F., & Mowery, P. D. (2001). Factors associated with discrepancies between self-reports on cigarette smoking and measured serum cotinine levels among persons aged 17 years or older: Third National Health and Nutrition Examination Survey, 1988-1994. American Journal of Epidemiology, 153, 807-814. (Pubitemid 32319710)
5. Fergusson, D. M., Woodward, L. J., & Horwood, L. J. (1998). Maternal smoking during pregnancy and psychiatric adjustment in late adolescence. Archives of General Psychiatry, 55, 721-727. (Pubitemid 28364389)
6. Florescu, A., Ferrence, R., Einarson, T., Selby, P., Soldin, O., & Koren, G. (2009). Methods for quantification of exposure to cigarette smoking and environmental tobacco smoke: Focus on developmental toxicology. Therpeutic Drug Monitoring, 31, 14-30.
7. Jarvis, M. J., Fidler, J., Mindell, J., Feyerabend, C., & West, R. (2008). Assessing smoking status in children, adolescents and adults: Cotinine cut-points revisited. Addiction, 103, 1553-1561.
8. Jefferis, B. J., Lawlor, D. A., Ebrahim, S., Wannamethee, S. G., Feyerabend, C., Doig, M., McMeekin, L., Cook, D. G., & Whincup, P. H. (2010). Cotinine-assessed second-hand smoke exposure and risk of cardiovascular disease in older adults. Heart, 96, 854-859.
9. Martinez, M. E., Reid, M., Jiang, R., Einspahr, J., & Alberts, D. S. (2004). Accuracy of self-reported smoking status among participants in a chemoprevention trial. Preventive Medicine, 38, 492-497. (Pubitemid 38327022)
10. Nondahl, D. M., Cruickshanks, K. J., & Schubert, C. R. (2005). A questionnaire for assessing environmental tobacco smoke exposure. Environmental Research, 97, 76-82. (Pubitemid 39336393)
11. Reaven, G., & Tsao, P. S. (2003). Insulin resistance and compensatory hyperinsulinemia: The key player between cigarette smoking and cardiovascular disease Journal of the American College of Cardiology, 41, 1044-1047.
12. Sandhu, S., Humphris, G., Whitley, S., Cardozo, A., & Sandhu, A. (2004). Smoking habits in patient's who have been treated for an oral cancer: Validation of self-report using saliva cotinine. Oral Oncology, 40, 576-578. (Pubitemid 38452676)
13. SRNTSubcommitteeonBiochemicalVerification.(2002). Biochemical verification of tobacco use and cessation. Nicotine Tobacco Research,4,149-159.
14. Teo, K. K., Ounpuu, S., Hawken, S., Pandey, M. R., Valentin, V., Hunt, D., Diaz, R., Rashed, W., Freeman, R., Jiang, L., Zhang, X., Yusuf, S., & INTERHEART Study Investigators. (2006). Tobacco use and risk of myocardial infarction in 52 countries in the INTERHEART study: A case-control study. Lancet, 368, 647-658. (Pubitemid 44223693)
15. Vartiainen, E., Seppala, T., Lillsunde, P., & Puska, P. (2002). Validation of self reported smoking by serum cotinine measurement in a community-based study. Journal of Epidemiology and Community Health, 56, 167-170. (Pubitemid 34174437)
16. Wells, A. J., English, P. B., Posner, S. F., Wagenknecht, L. E., & Perez-Stable, E. J. (1998). Misclassification rates for current smokers misclassified as nonsmokers. American Journal of Public Health, 88, 1503-1509. (Pubitemid 28455758)
17. Whincup, P. H., Gilg, J. A., Emberson, J. R., Jarvis, M. J., Feyerabend, C., Bryant, A., Walker, M., & Cook, D. G. (2004). Passive smoking and risk of coronary heart disease and stroke: Prospective study with cotinine measurement. BMJ, 329, 200-205.
18. Winkelmann, B. R., Marz,W., Boehm, B. O., Zotz, R., Hager, J., Hellstern, P., Senges, J., & LURIC Study Group (LUdwigshafen RIsk and Cardiovascular Health). (2001). Rationale and design of the LURIC study-a resource for functional genomics, pharmacogenomics and long-term prognosis of cardiovascular disease. Pharmacogenomics, 2, S1-S73.